Global Long-Acting Injectables Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Long-Acting Injectables market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
The Global Info Research report includes an overview of the development of the Long-Acting Injectables industry chain, the market status of Schizophrenia (Small and Middle Sized Molecule, Large Sized Molecule), Other Psychotic Disorders (Small and Middle Sized Molecule, Large Sized Molecule), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long-Acting Injectables.
Regionally, the report analyzes the Long-Acting Injectables markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long-Acting Injectables market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Long-Acting Injectables market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long-Acting Injectables industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small and Middle Sized Molecule, Large Sized Molecule).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long-Acting Injectables market.
Regional Analysis: The report involves examining the Long-Acting Injectables market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long-Acting Injectables market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Long-Acting Injectables:
Company Analysis: Report covers individual Long-Acting Injectables players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long-Acting Injectables This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Schizophrenia, Other Psychotic Disorders).
Technology Analysis: Report covers specific technologies relevant to Long-Acting Injectables. It assesses the current state, advancements, and potential future developments in Long-Acting Injectables areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long-Acting Injectables market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Long-Acting Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Long-Acting Injectables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long-Acting Injectables, with revenue, gross margin and global market share of Long-Acting Injectables from 2019 to 2024.
Chapter 3, the Long-Acting Injectables competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Long-Acting Injectables market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long-Acting Injectables.
Chapter 13, to describe Long-Acting Injectables research findings and conclusion.
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
The Global Info Research report includes an overview of the development of the Long-Acting Injectables industry chain, the market status of Schizophrenia (Small and Middle Sized Molecule, Large Sized Molecule), Other Psychotic Disorders (Small and Middle Sized Molecule, Large Sized Molecule), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long-Acting Injectables.
Regionally, the report analyzes the Long-Acting Injectables markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long-Acting Injectables market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Long-Acting Injectables market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long-Acting Injectables industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small and Middle Sized Molecule, Large Sized Molecule).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long-Acting Injectables market.
Regional Analysis: The report involves examining the Long-Acting Injectables market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long-Acting Injectables market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Long-Acting Injectables:
Company Analysis: Report covers individual Long-Acting Injectables players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long-Acting Injectables This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Schizophrenia, Other Psychotic Disorders).
Technology Analysis: Report covers specific technologies relevant to Long-Acting Injectables. It assesses the current state, advancements, and potential future developments in Long-Acting Injectables areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long-Acting Injectables market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Long-Acting Injectables market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Small and Middle Sized Molecule
- Large Sized Molecule
- Schizophrenia
- Other Psychotic Disorders
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Johnson & Johnson
- Lupin
- Zogenix
- DURECT
- Medincel
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Long-Acting Injectables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long-Acting Injectables, with revenue, gross margin and global market share of Long-Acting Injectables from 2019 to 2024.
Chapter 3, the Long-Acting Injectables competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Long-Acting Injectables market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long-Acting Injectables.
Chapter 13, to describe Long-Acting Injectables research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Long-Acting Injectables
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long-Acting Injectables by Type
1.3.1 Overview: Global Long-Acting Injectables Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Long-Acting Injectables Consumption Value Market Share by Type in 2023
1.3.3 Small and Middle Sized Molecule
1.3.4 Large Sized Molecule
1.4 Global Long-Acting Injectables Market by Application
1.4.1 Overview: Global Long-Acting Injectables Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Schizophrenia
1.4.3 Other Psychotic Disorders
1.5 Global Long-Acting Injectables Market Size & Forecast
1.6 Global Long-Acting Injectables Market Size and Forecast by Region
1.6.1 Global Long-Acting Injectables Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Long-Acting Injectables Market Size by Region, (2019-2030)
1.6.3 North America Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.4 Europe Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.6 South America Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Long-Acting Injectables Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Long-Acting Injectables Product and Solutions
2.1.4 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Long-Acting Injectables Product and Solutions
2.2.4 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Long-Acting Injectables Product and Solutions
2.3.4 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Long-Acting Injectables Product and Solutions
2.4.4 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Long-Acting Injectables Product and Solutions
2.5.4 Lupin Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lupin Recent Developments and Future Plans
2.6 Zogenix
2.6.1 Zogenix Details
2.6.2 Zogenix Major Business
2.6.3 Zogenix Long-Acting Injectables Product and Solutions
2.6.4 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zogenix Recent Developments and Future Plans
2.7 DURECT
2.7.1 DURECT Details
2.7.2 DURECT Major Business
2.7.3 DURECT Long-Acting Injectables Product and Solutions
2.7.4 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 DURECT Recent Developments and Future Plans
2.8 Medincel
2.8.1 Medincel Details
2.8.2 Medincel Major Business
2.8.3 Medincel Long-Acting Injectables Product and Solutions
2.8.4 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Medincel Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long-Acting Injectables Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Long-Acting Injectables by Company Revenue
3.2.2 Top 3 Long-Acting Injectables Players Market Share in 2023
3.2.3 Top 6 Long-Acting Injectables Players Market Share in 2023
3.3 Long-Acting Injectables Market: Overall Company Footprint Analysis
3.3.1 Long-Acting Injectables Market: Region Footprint
3.3.2 Long-Acting Injectables Market: Company Product Type Footprint
3.3.3 Long-Acting Injectables Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long-Acting Injectables Consumption Value and Market Share by Type (2019-2024)
4.2 Global Long-Acting Injectables Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long-Acting Injectables Consumption Value Market Share by Application (2019-2024)
5.2 Global Long-Acting Injectables Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Long-Acting Injectables Consumption Value by Type (2019-2030)
6.2 North America Long-Acting Injectables Consumption Value by Application (2019-2030)
6.3 North America Long-Acting Injectables Market Size by Country
6.3.1 North America Long-Acting Injectables Consumption Value by Country (2019-2030)
6.3.2 United States Long-Acting Injectables Market Size and Forecast (2019-2030)
6.3.3 Canada Long-Acting Injectables Market Size and Forecast (2019-2030)
6.3.4 Mexico Long-Acting Injectables Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Long-Acting Injectables Consumption Value by Type (2019-2030)
7.2 Europe Long-Acting Injectables Consumption Value by Application (2019-2030)
7.3 Europe Long-Acting Injectables Market Size by Country
7.3.1 Europe Long-Acting Injectables Consumption Value by Country (2019-2030)
7.3.2 Germany Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.3 France Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.5 Russia Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.6 Italy Long-Acting Injectables Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long-Acting Injectables Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Long-Acting Injectables Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Long-Acting Injectables Market Size by Region
8.3.1 Asia-Pacific Long-Acting Injectables Consumption Value by Region (2019-2030)
8.3.2 China Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.3 Japan Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.4 South Korea Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.5 India Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.7 Australia Long-Acting Injectables Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Long-Acting Injectables Consumption Value by Type (2019-2030)
9.2 South America Long-Acting Injectables Consumption Value by Application (2019-2030)
9.3 South America Long-Acting Injectables Market Size by Country
9.3.1 South America Long-Acting Injectables Consumption Value by Country (2019-2030)
9.3.2 Brazil Long-Acting Injectables Market Size and Forecast (2019-2030)
9.3.3 Argentina Long-Acting Injectables Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long-Acting Injectables Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Long-Acting Injectables Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country
10.3.1 Middle East & Africa Long-Acting Injectables Consumption Value by Country (2019-2030)
10.3.2 Turkey Long-Acting Injectables Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Long-Acting Injectables Market Size and Forecast (2019-2030)
10.3.4 UAE Long-Acting Injectables Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Long-Acting Injectables Market Drivers
11.2 Long-Acting Injectables Market Restraints
11.3 Long-Acting Injectables Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Long-Acting Injectables Industry Chain
12.2 Long-Acting Injectables Upstream Analysis
12.3 Long-Acting Injectables Midstream Analysis
12.4 Long-Acting Injectables Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Long-Acting Injectables
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long-Acting Injectables by Type
1.3.1 Overview: Global Long-Acting Injectables Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Long-Acting Injectables Consumption Value Market Share by Type in 2023
1.3.3 Small and Middle Sized Molecule
1.3.4 Large Sized Molecule
1.4 Global Long-Acting Injectables Market by Application
1.4.1 Overview: Global Long-Acting Injectables Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Schizophrenia
1.4.3 Other Psychotic Disorders
1.5 Global Long-Acting Injectables Market Size & Forecast
1.6 Global Long-Acting Injectables Market Size and Forecast by Region
1.6.1 Global Long-Acting Injectables Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Long-Acting Injectables Market Size by Region, (2019-2030)
1.6.3 North America Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.4 Europe Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.6 South America Long-Acting Injectables Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Long-Acting Injectables Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Long-Acting Injectables Product and Solutions
2.1.4 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Long-Acting Injectables Product and Solutions
2.2.4 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Long-Acting Injectables Product and Solutions
2.3.4 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Long-Acting Injectables Product and Solutions
2.4.4 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Long-Acting Injectables Product and Solutions
2.5.4 Lupin Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lupin Recent Developments and Future Plans
2.6 Zogenix
2.6.1 Zogenix Details
2.6.2 Zogenix Major Business
2.6.3 Zogenix Long-Acting Injectables Product and Solutions
2.6.4 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zogenix Recent Developments and Future Plans
2.7 DURECT
2.7.1 DURECT Details
2.7.2 DURECT Major Business
2.7.3 DURECT Long-Acting Injectables Product and Solutions
2.7.4 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 DURECT Recent Developments and Future Plans
2.8 Medincel
2.8.1 Medincel Details
2.8.2 Medincel Major Business
2.8.3 Medincel Long-Acting Injectables Product and Solutions
2.8.4 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Medincel Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long-Acting Injectables Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Long-Acting Injectables by Company Revenue
3.2.2 Top 3 Long-Acting Injectables Players Market Share in 2023
3.2.3 Top 6 Long-Acting Injectables Players Market Share in 2023
3.3 Long-Acting Injectables Market: Overall Company Footprint Analysis
3.3.1 Long-Acting Injectables Market: Region Footprint
3.3.2 Long-Acting Injectables Market: Company Product Type Footprint
3.3.3 Long-Acting Injectables Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long-Acting Injectables Consumption Value and Market Share by Type (2019-2024)
4.2 Global Long-Acting Injectables Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long-Acting Injectables Consumption Value Market Share by Application (2019-2024)
5.2 Global Long-Acting Injectables Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Long-Acting Injectables Consumption Value by Type (2019-2030)
6.2 North America Long-Acting Injectables Consumption Value by Application (2019-2030)
6.3 North America Long-Acting Injectables Market Size by Country
6.3.1 North America Long-Acting Injectables Consumption Value by Country (2019-2030)
6.3.2 United States Long-Acting Injectables Market Size and Forecast (2019-2030)
6.3.3 Canada Long-Acting Injectables Market Size and Forecast (2019-2030)
6.3.4 Mexico Long-Acting Injectables Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Long-Acting Injectables Consumption Value by Type (2019-2030)
7.2 Europe Long-Acting Injectables Consumption Value by Application (2019-2030)
7.3 Europe Long-Acting Injectables Market Size by Country
7.3.1 Europe Long-Acting Injectables Consumption Value by Country (2019-2030)
7.3.2 Germany Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.3 France Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.5 Russia Long-Acting Injectables Market Size and Forecast (2019-2030)
7.3.6 Italy Long-Acting Injectables Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long-Acting Injectables Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Long-Acting Injectables Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Long-Acting Injectables Market Size by Region
8.3.1 Asia-Pacific Long-Acting Injectables Consumption Value by Region (2019-2030)
8.3.2 China Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.3 Japan Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.4 South Korea Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.5 India Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Long-Acting Injectables Market Size and Forecast (2019-2030)
8.3.7 Australia Long-Acting Injectables Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Long-Acting Injectables Consumption Value by Type (2019-2030)
9.2 South America Long-Acting Injectables Consumption Value by Application (2019-2030)
9.3 South America Long-Acting Injectables Market Size by Country
9.3.1 South America Long-Acting Injectables Consumption Value by Country (2019-2030)
9.3.2 Brazil Long-Acting Injectables Market Size and Forecast (2019-2030)
9.3.3 Argentina Long-Acting Injectables Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long-Acting Injectables Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Long-Acting Injectables Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country
10.3.1 Middle East & Africa Long-Acting Injectables Consumption Value by Country (2019-2030)
10.3.2 Turkey Long-Acting Injectables Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Long-Acting Injectables Market Size and Forecast (2019-2030)
10.3.4 UAE Long-Acting Injectables Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Long-Acting Injectables Market Drivers
11.2 Long-Acting Injectables Market Restraints
11.3 Long-Acting Injectables Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Long-Acting Injectables Industry Chain
12.2 Long-Acting Injectables Upstream Analysis
12.3 Long-Acting Injectables Midstream Analysis
12.4 Long-Acting Injectables Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Long-Acting Injectables Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Long-Acting Injectables Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Long-Acting Injectables Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Eli Lilly Company Information, Head Office, and Major Competitors
Table 6. Eli Lilly Major Business
Table 7. Eli Lilly Long-Acting Injectables Product and Solutions
Table 8. Eli Lilly Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Eli Lilly Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Long-Acting Injectables Product and Solutions
Table 13. Pfizer Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Long-Acting Injectables Product and Solutions
Table 18. GlaxoSmithKline Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GlaxoSmithKline Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Long-Acting Injectables Product and Solutions
Table 23. Johnson & Johnson Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Lupin Company Information, Head Office, and Major Competitors
Table 26. Lupin Major Business
Table 27. Lupin Long-Acting Injectables Product and Solutions
Table 28. Lupin Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Lupin Recent Developments and Future Plans
Table 30. Zogenix Company Information, Head Office, and Major Competitors
Table 31. Zogenix Major Business
Table 32. Zogenix Long-Acting Injectables Product and Solutions
Table 33. Zogenix Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Zogenix Recent Developments and Future Plans
Table 35. DURECT Company Information, Head Office, and Major Competitors
Table 36. DURECT Major Business
Table 37. DURECT Long-Acting Injectables Product and Solutions
Table 38. DURECT Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. DURECT Recent Developments and Future Plans
Table 40. Medincel Company Information, Head Office, and Major Competitors
Table 41. Medincel Major Business
Table 42. Medincel Long-Acting Injectables Product and Solutions
Table 43. Medincel Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Medincel Recent Developments and Future Plans
Table 45. Global Long-Acting Injectables Revenue (USD Million) by Players (2019-2024)
Table 46. Global Long-Acting Injectables Revenue Share by Players (2019-2024)
Table 47. Breakdown of Long-Acting Injectables by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Long-Acting Injectables, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 49. Head Office of Key Long-Acting Injectables Players
Table 50. Long-Acting Injectables Market: Company Product Type Footprint
Table 51. Long-Acting Injectables Market: Company Product Application Footprint
Table 52. Long-Acting Injectables New Market Entrants and Barriers to Market Entry
Table 53. Long-Acting Injectables Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Long-Acting Injectables Consumption Value (USD Million) by Type (2019-2024)
Table 55. Global Long-Acting Injectables Consumption Value Share by Type (2019-2024)
Table 56. Global Long-Acting Injectables Consumption Value Forecast by Type (2025-2030)
Table 57. Global Long-Acting Injectables Consumption Value by Application (2019-2024)
Table 58. Global Long-Acting Injectables Consumption Value Forecast by Application (2025-2030)
Table 59. North America Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 60. North America Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 61. North America Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 62. North America Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 63. North America Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 64. North America Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Europe Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Europe Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Europe Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Europe Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Europe Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Asia-Pacific Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Asia-Pacific Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 74. Asia-Pacific Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 75. Asia-Pacific Long-Acting Injectables Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Asia-Pacific Long-Acting Injectables Consumption Value by Region (2025-2030) & (USD Million)
Table 77. South America Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 78. South America Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 79. South America Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 80. South America Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 81. South America Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 84. Middle East & Africa Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 85. Middle East & Africa Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 86. Middle East & Africa Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 87. Middle East & Africa Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 88. Middle East & Africa Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Long-Acting Injectables Raw Material
Table 90. Key Suppliers of Long-Acting Injectables Raw Materials
Table 1. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Long-Acting Injectables Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Long-Acting Injectables Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Long-Acting Injectables Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Eli Lilly Company Information, Head Office, and Major Competitors
Table 6. Eli Lilly Major Business
Table 7. Eli Lilly Long-Acting Injectables Product and Solutions
Table 8. Eli Lilly Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Eli Lilly Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Long-Acting Injectables Product and Solutions
Table 13. Pfizer Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Long-Acting Injectables Product and Solutions
Table 18. GlaxoSmithKline Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GlaxoSmithKline Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Long-Acting Injectables Product and Solutions
Table 23. Johnson & Johnson Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Lupin Company Information, Head Office, and Major Competitors
Table 26. Lupin Major Business
Table 27. Lupin Long-Acting Injectables Product and Solutions
Table 28. Lupin Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Lupin Recent Developments and Future Plans
Table 30. Zogenix Company Information, Head Office, and Major Competitors
Table 31. Zogenix Major Business
Table 32. Zogenix Long-Acting Injectables Product and Solutions
Table 33. Zogenix Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Zogenix Recent Developments and Future Plans
Table 35. DURECT Company Information, Head Office, and Major Competitors
Table 36. DURECT Major Business
Table 37. DURECT Long-Acting Injectables Product and Solutions
Table 38. DURECT Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. DURECT Recent Developments and Future Plans
Table 40. Medincel Company Information, Head Office, and Major Competitors
Table 41. Medincel Major Business
Table 42. Medincel Long-Acting Injectables Product and Solutions
Table 43. Medincel Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Medincel Recent Developments and Future Plans
Table 45. Global Long-Acting Injectables Revenue (USD Million) by Players (2019-2024)
Table 46. Global Long-Acting Injectables Revenue Share by Players (2019-2024)
Table 47. Breakdown of Long-Acting Injectables by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Long-Acting Injectables, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 49. Head Office of Key Long-Acting Injectables Players
Table 50. Long-Acting Injectables Market: Company Product Type Footprint
Table 51. Long-Acting Injectables Market: Company Product Application Footprint
Table 52. Long-Acting Injectables New Market Entrants and Barriers to Market Entry
Table 53. Long-Acting Injectables Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Long-Acting Injectables Consumption Value (USD Million) by Type (2019-2024)
Table 55. Global Long-Acting Injectables Consumption Value Share by Type (2019-2024)
Table 56. Global Long-Acting Injectables Consumption Value Forecast by Type (2025-2030)
Table 57. Global Long-Acting Injectables Consumption Value by Application (2019-2024)
Table 58. Global Long-Acting Injectables Consumption Value Forecast by Application (2025-2030)
Table 59. North America Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 60. North America Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 61. North America Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 62. North America Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 63. North America Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 64. North America Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Europe Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Europe Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Europe Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Europe Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Europe Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Asia-Pacific Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Asia-Pacific Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 74. Asia-Pacific Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 75. Asia-Pacific Long-Acting Injectables Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Asia-Pacific Long-Acting Injectables Consumption Value by Region (2025-2030) & (USD Million)
Table 77. South America Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 78. South America Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 79. South America Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 80. South America Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 81. South America Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa Long-Acting Injectables Consumption Value by Type (2019-2024) & (USD Million)
Table 84. Middle East & Africa Long-Acting Injectables Consumption Value by Type (2025-2030) & (USD Million)
Table 85. Middle East & Africa Long-Acting Injectables Consumption Value by Application (2019-2024) & (USD Million)
Table 86. Middle East & Africa Long-Acting Injectables Consumption Value by Application (2025-2030) & (USD Million)
Table 87. Middle East & Africa Long-Acting Injectables Consumption Value by Country (2019-2024) & (USD Million)
Table 88. Middle East & Africa Long-Acting Injectables Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Long-Acting Injectables Raw Material
Table 90. Key Suppliers of Long-Acting Injectables Raw Materials
LIST OF FIGURES
Figure 1. Long-Acting Injectables Picture
Figure 2. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Long-Acting Injectables Consumption Value Market Share by Type in 2023
Figure 4. Small and Middle Sized Molecule
Figure 5. Large Sized Molecule
Figure 6. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Long-Acting Injectables Consumption Value Market Share by Application in 2023
Figure 8. Schizophrenia Picture
Figure 9. Other Psychotic Disorders Picture
Figure 10. Global Long-Acting Injectables Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Long-Acting Injectables Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Long-Acting Injectables Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Long-Acting Injectables Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Long-Acting Injectables Consumption Value Market Share by Region in 2023
Figure 15. North America Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Long-Acting Injectables Revenue Share by Players in 2023
Figure 21. Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Long-Acting Injectables Market Share in 2023
Figure 23. Global Top 6 Players Long-Acting Injectables Market Share in 2023
Figure 24. Global Long-Acting Injectables Consumption Value Share by Type (2019-2024)
Figure 25. Global Long-Acting Injectables Market Share Forecast by Type (2025-2030)
Figure 26. Global Long-Acting Injectables Consumption Value Share by Application (2019-2024)
Figure 27. Global Long-Acting Injectables Market Share Forecast by Application (2025-2030)
Figure 28. North America Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 38. France Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Region (2019-2030)
Figure 45. China Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 48. India Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 62. Long-Acting Injectables Market Drivers
Figure 63. Long-Acting Injectables Market Restraints
Figure 64. Long-Acting Injectables Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Long-Acting Injectables in 2023
Figure 67. Manufacturing Process Analysis of Long-Acting Injectables
Figure 68. Long-Acting Injectables Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Long-Acting Injectables Picture
Figure 2. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Long-Acting Injectables Consumption Value Market Share by Type in 2023
Figure 4. Small and Middle Sized Molecule
Figure 5. Large Sized Molecule
Figure 6. Global Long-Acting Injectables Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Long-Acting Injectables Consumption Value Market Share by Application in 2023
Figure 8. Schizophrenia Picture
Figure 9. Other Psychotic Disorders Picture
Figure 10. Global Long-Acting Injectables Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Long-Acting Injectables Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Long-Acting Injectables Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Long-Acting Injectables Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Long-Acting Injectables Consumption Value Market Share by Region in 2023
Figure 15. North America Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Long-Acting Injectables Revenue Share by Players in 2023
Figure 21. Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Long-Acting Injectables Market Share in 2023
Figure 23. Global Top 6 Players Long-Acting Injectables Market Share in 2023
Figure 24. Global Long-Acting Injectables Consumption Value Share by Type (2019-2024)
Figure 25. Global Long-Acting Injectables Market Share Forecast by Type (2025-2030)
Figure 26. Global Long-Acting Injectables Consumption Value Share by Application (2019-2024)
Figure 27. Global Long-Acting Injectables Market Share Forecast by Application (2025-2030)
Figure 28. North America Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 38. France Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Long-Acting Injectables Consumption Value Market Share by Region (2019-2030)
Figure 45. China Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 48. India Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Long-Acting Injectables Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Long-Acting Injectables Consumption Value (2019-2030) & (USD Million)
Figure 62. Long-Acting Injectables Market Drivers
Figure 63. Long-Acting Injectables Market Restraints
Figure 64. Long-Acting Injectables Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Long-Acting Injectables in 2023
Figure 67. Manufacturing Process Analysis of Long-Acting Injectables
Figure 68. Long-Acting Injectables Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
